Related Experiment Video
Updated: Jun 16, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal
Giuseppe Castellano1, Rita Melchiorre, Antonia Loverre
1Department of Emergency and Organ Transplantation, University of Bari, Policlinico, Piazza Giulio Cesare 11, Bari, Italy. g.castellano@nephro.uniba.it
Abstract:
Ischemia-reperfusion injury is the major cause of delayed graft function in transplanted kidneys, an early event significantly affecting long-term graft function and survival. Several studies in rodents suggest that the alternative pathway of the complement system plays a pivotal role in renal ischemia-reperfusion injury. However, limited information is currently available from humans and larger animals. Here we demonstrated that 30 minutes of ischemia resulted in the induction of C4d/C1q, C4d/MLB, and MBL/MASP-2 deposits in a swine model of ischemia-reperfusion injury. The infusion of C1-inhibitor led to a significant reduction in peritubular capillary and glomerular C4d and C5b-9 deposition. Moreover, complement-inhibiting treatment significantly reduced the numbers of infiltrating CD163(+), SWC3a(+), CD4a(+), and CD8a(+) cells. C1-inhibitor administration led to significant inhibition of tubular damage and tubular epithelial cells apoptosis. Interestingly, we report that focal C4d-deposition colocalizes with C1q and MBL at the peritubular and glomerular capillary levels also in patients with delayed graft function. In conclusion, we demonstrated the activation and a pathogenic role of classical and lectin pathways of complement in a swine model of ischemia-reperfusion-induced renal damage. Therefore, inhibition of these two pathways might represent a novel therapeutic approach in the prevention of delayed graft function in kidney transplant recipients.
Insights
Kidney transplant ischemia-reperfusion injury involves complement pathways. Inhibiting classical and lectin pathways reduces damage and may prevent delayed graft function.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Ischemia-reperfusion injury (IRI) is a primary cause of delayed graft function in kidney transplantation.
- The alternative complement pathway's role in IRI is known in rodents, but human and large animal data are limited.
Purpose of the Study:
- To investigate the role of complement pathways in renal IRI using a swine model.
- To evaluate the therapeutic potential of C1-inhibitor in mitigating IRI-induced kidney damage.
Main Methods:
- A swine model of renal IRI was established.
- Complement deposition (C4d/C1q, C4d/MLB, MBL/MASP-2) was assessed post-ischemia.
- C1-inhibitor was administered to assess its effects on complement deposition, immune cell infiltration, tubular damage, and apoptosis.
- Human kidney transplant biopsies with delayed graft function were analyzed for complement deposition.
Main Results:
- Ischemia induced C4d/C1q, C4d/MLB, and MBL/MASP-2 deposition in swine kidneys.
- C1-inhibitor treatment significantly reduced C4d and C5b-9 deposition, immune cell infiltration, tubular damage, and apoptosis.
- Focal C4d deposition co-localized with C1q and MBL in human delayed graft function biopsies.
Conclusions:
- The classical and lectin complement pathways are activated and play a pathogenic role in swine renal IRI.
- C1-inhibitor effectively mitigates IRI-induced renal damage in a large animal model.
- Inhibiting these complement pathways may offer a novel therapeutic strategy for preventing delayed graft function in kidney transplant recipients.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury I: Introduction
